AR029188A1 - Procedimiento para preparar un inhibidor del intercambiador de sodio-hidrogeno tipo 1 - Google Patents

Procedimiento para preparar un inhibidor del intercambiador de sodio-hidrogeno tipo 1

Info

Publication number
AR029188A1
AR029188A1 ARP000105697A ARP000105697A AR029188A1 AR 029188 A1 AR029188 A1 AR 029188A1 AR P000105697 A ARP000105697 A AR P000105697A AR P000105697 A ARP000105697 A AR P000105697A AR 029188 A1 AR029188 A1 AR 029188A1
Authority
AR
Argentina
Prior art keywords
procedure
prepare
sodium
type
hydrogen exchanger
Prior art date
Application number
ARP000105697A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR029188A1 publication Critical patent/AR029188A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/10—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP000105697A 1999-10-29 2000-10-27 Procedimiento para preparar un inhibidor del intercambiador de sodio-hidrogeno tipo 1 AR029188A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16237799P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
AR029188A1 true AR029188A1 (es) 2003-06-18

Family

ID=22585372

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105697A AR029188A1 (es) 1999-10-29 2000-10-27 Procedimiento para preparar un inhibidor del intercambiador de sodio-hidrogeno tipo 1

Country Status (19)

Country Link
US (1) US6441176B1 (enExample)
EP (1) EP1101763A3 (enExample)
JP (1) JP3342475B2 (enExample)
KR (2) KR100449595B1 (enExample)
CN (1) CN1146557C (enExample)
AR (1) AR029188A1 (enExample)
AU (1) AU779106B2 (enExample)
BR (1) BR0005122A (enExample)
CA (1) CA2324640A1 (enExample)
CZ (1) CZ20004018A3 (enExample)
HU (1) HUP0004187A2 (enExample)
ID (1) ID27904A (enExample)
IL (1) IL139198A0 (enExample)
PL (1) PL343542A1 (enExample)
RU (1) RU2190605C2 (enExample)
TR (1) TR200003143A2 (enExample)
TW (1) TWI221152B (enExample)
YU (1) YU62900A (enExample)
ZA (1) ZA200006007B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852733B2 (en) 2000-04-28 2005-02-08 Pfizer Inc. Sodium-hydrogen exchanger type 1 inhibitor
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (es) * 2001-12-19 2004-08-12 Pfizer Prod Inc Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028381A (en) * 1975-05-05 1977-06-07 Ciba-Geigy Corporation Pyrazolobenzazepines
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
RU2009129C1 (ru) * 1991-12-16 1994-03-15 Центр по химии лекарственных средств Арилгидразоны 5,6,7,8-тетрагидрохинолиндионы-2,5, обладающие кардиотонической активностью
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
JP2002504546A (ja) 1998-02-27 2002-02-12 ファイザー・プロダクツ・インク 虚血の治療のためのn−[(置換5員ジもしくはトリアザ二不飽和環)カルボニル]グアニジン誘導体
UA72002C2 (en) 1999-10-29 2005-01-17 Pfizer Prod Inc Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage

Also Published As

Publication number Publication date
YU62900A (sh) 2003-08-29
KR100449595B1 (ko) 2004-09-21
CA2324640A1 (en) 2001-04-29
TR200003143A2 (tr) 2001-05-21
JP3342475B2 (ja) 2002-11-11
CN1146557C (zh) 2004-04-21
US6441176B1 (en) 2002-08-27
PL343542A1 (en) 2001-05-07
KR20010060211A (ko) 2001-07-06
IL139198A0 (en) 2001-11-25
RU2190605C2 (ru) 2002-10-10
CZ20004018A3 (cs) 2002-04-17
ID27904A (id) 2001-05-03
TWI221152B (en) 2004-09-21
JP2001158784A (ja) 2001-06-12
BR0005122A (pt) 2001-06-19
HK1036057A1 (en) 2003-07-10
CN1295070A (zh) 2001-05-16
ZA200006007B (en) 2002-04-26
EP1101763A3 (en) 2002-04-24
EP1101763A2 (en) 2001-05-23
HUP0004187A2 (hu) 2002-11-28
AU6133300A (en) 2001-05-03
AU779106B2 (en) 2005-01-06
KR20030061767A (ko) 2003-07-22
KR100443851B1 (ko) 2004-08-11
HU0004187D0 (enExample) 2001-01-29

Similar Documents

Publication Publication Date Title
WO2003050261A3 (en) (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
RU2000106434A (ru) N-алканоилфенилаланиновые производные
ES2080297T3 (es) Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.
EA201170607A1 (ru) Акриламидопроизводные, применимые как ингибиторы перехода митохондриальной проницаемости
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
GT200000167A (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas.
ES478199A1 (es) Un procedimiento para la preparacion de etalazinas.
NO20020938D0 (no) Substituerte alfa-hydroksysyre-caspaseinhibitorer og deres anvendelse
AR125026A1 (es) Inhibidores del sarcómero cardíaco
TR200103067T2 (tr) Renin inhibitörleri
ES2153491T3 (es) Derivados de quinazolina.
ES2192183T3 (es) Derivados de imidazopiridina como inhibidores de fosfodiesterasa vii.
UY28528A1 (es) Nuevos compuestos
AR026925A1 (es) Nuevos derivados de azabiciclooctano utiles en el tratamiento de arritmias cardiacas
SE0100326D0 (sv) New compounds
WO2002102301A3 (en) Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
PA8534001A1 (es) Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
AR071049A1 (es) Uso de n- fenilamidas de acido 2- sulfonilaminobenzoidco sustituidas con sulfonilo en el tratamiento del dolor
ES8103729A1 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
BR0113374A (pt) Derivados de bifenila e seu uso como inibidores da integrina
AR029229A1 (es) Compuestos de piperazina sustituida, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento
AR035601A1 (es) Procesos de preparacion de inhibidores del intercambiador de sodio-hidrogeno de tipo 1, inhibidores, sales de dichos compuestos, composiciones farmaceuticas y uso de los mismos en la preparación de medicamentos
SV1997000033A (es) Derivados de acido 4-arilbutirico sustituido como inhibisor de matriz de metaloproteasa
DE69702419D1 (de) Substituierte Guanidin Derivate und ihre Verwendung als Na+/H+ Austausch Inhibitoren

Legal Events

Date Code Title Description
FB Suspension of granting procedure